Partner Content Partner Content UserWise to lead a post-conference workshop at Pre-Filled Sy... Pre-Filled Syringes West Coast 2019
Partner Content Partner Content Exclusive speaker interviews with Merck and Sanofi - Injecta... SMi’s Injectable Drug Delivery Conference
Partner Content Partner Content Conference Chair from MedinCell invites you to attend Inject... Injectable Drug Delivery Conference
Partner Content Partner Content Exclusive speaker interview released: Sumitomo Rubber ahead ... Pre-Filled Syringes West Coast
Partner Content Partner Content Four weeks until Adaptive Designs in Clinical Trials Confere... Four weeks until SMi’s 11th Annual Conference
Partner Content Partner Content Regulatory Updates and Patient Safety at Injectable Drug Del... Injectable Drug Delivery 2019 - workshop
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
